1. Home
  2. SOLS vs SNN Comparison

SOLS vs SNN Comparison

Compare SOLS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$81.57

Market Cap

11.9B

Sector

Industrials

ML Signal

N/A

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$33.40

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOLS
SNN
Founded
2025
1856
Country
United States
United Kingdom
Employees
4400
N/A
Industry
Aerospace
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
14.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOLS
SNN
Price
$81.57
$33.40
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$72.75
$36.25
AVG Volume (30 Days)
1.8M
659.5K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
0.36%
2.27%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.46
$8.61
Revenue Next Year
$5.46
$5.60
P/E Ratio
$54.31
$64.97
Revenue Growth
N/A
N/A
52 Week Low
$40.43
$25.45
52 Week High
$84.44
$38.79

Technical Indicators

Market Signals
Indicator
SOLS
SNN
Relative Strength Index (RSI) 60.96 54.49
Support Level $69.12 $32.03
Resistance Level $83.07 $33.89
Average True Range (ATR) 3.02 0.54
MACD 0.78 0.23
Stochastic Oscillator 84.13 84.76

Price Performance

Historical Comparison
SOLS
SNN

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: